WHY IT MATTERS: The policies shaped by this kind of industry coalition could directly affect what medical cannabis products are available to patients, how they are labeled, and whether insurance or federal programs ever cover them. CLINICAL OVERVIEW: The formation of a cross-border cannabis industry coalition comes at a pivotal moment when federal rescheduling discussions in the United States are creating real regulatory uncertainty for both patients and producers. Industry-led organizations of this kind can play a meaningful role in shaping the evidentiary standards and policy frameworks that ultimately determine how patients access medical cannabis, what labeling and dosing information is required, and how physicians are permitted to recommend it.
DOJ Suggests ‘Frail and Elderly Grandmother’ Who Uses Medical Marijuana Could Face Armed Federal Agents
Ohio’s ability to identify and recall unsafe THC gummies proves that legal, regulated markets protect consumers in ways that unregulated black markets never can. Marijuana Moment reports on a DOJ filing suggesting that even a ‘frail and elderly grandmother’ who uses medical marijuana could theoretically face enforcement by armed federal agents under current law. The argument arose in litigation over the intersection of cannabis use and firearms rights under the Second Amendment.